Question 1

What’s the financial overview for Harmony Biosciences Holdings, Inc.?

Accepted Answer

Harmony Biosciences Holdings, Inc.’s market cap stands at $0.002 trillion right now. The company’s trailing twelve-month earnings per share EPS is $2.62, with a dividend yield of N/A%. Their next earnings report is set for January 29, 2025, and the estimated EPS for that period is $1.61. You can also check out summaries of their income statement, balance sheet, and cash flow details for a fuller picture of their financials.

Question 2

How can I analyze historical data?

Accepted Answer

To analyze historical data with AI tools, apply the date range filter above the table to focus on a specific period. The table displays daily open, high, low, close prices, and volume, enabling you to spot trends and patterns. Use these insights to make informed decisions based on historical performance.

Question 3

What does Harmony Biosciences Holdings, Inc. Stock ROE tell us?

Accepted Answer

Harmony Biosciences Holdings, Inc. stock ROE shows positive market sentiment. A higher ROE means the company’s management is doing a better job at using equity financing to drive income and growth. It’s a handy metric for comparing how a company stacks up against its competitors or the broader market.

Question 4

What do Analysts say about Harmony Biosciences Holdings, Inc.?

Accepted Answer

3 number of Analysts recommended buying Harmony Biosciences Holdings, Inc. the stock and 2 analysts recommended selling the stock.

Metric	Q4 2024	Q3 2024	Q2 2024	Q1 2024
Revenue	$201.27M	$186.04M	$172.81M	$154.62M
Cost of Revenue	$54.41M	$42.78M	$38.10M	$33.45M
Gross Profit	$146.86M	$143.26M	$134.71M	$121.17M
Gross Profit Ratio	$0.73	$0.77	$0.78	$0.78
R&D Expenses	$34.67M	$25.39M	$63.58M	$22.19M
SG&A Expenses	$56.47M	$56.16M	$49.77M	$46.95M
Operating Expenses	$91.13M	$81.55M	$113.35M	$69.14M
Total Costs & Expenses	$145.54M	$124.33M	$151.46M	$102.58M
Interest Income	$4.48M	$4.93M	$4.71M	$4.43M
Interest Expense	$4.21M	$4.35M	$4.40M	$4.54M
Depreciation & Amortization	$5.97M	$5.97M	$6.05M	$6.12M
EBITDA	$66.33M	$72.49M	$27.41M	$58.16M
EBITDA Ratio	$0.33	$0.39	$0.16	$0.38
Operating Income	$55.73M	$61.71M	$21.36M	$52.03M
Operating Income Ratio	$0.28	$0.33	$0.12	$0.34
Other Income/Expenses (Net)	$428000.00	$460000.00	$338000.00	-$248000.00
Income Before Tax	$56.16M	$62.17M	$21.69M	$51.78M
Income Before Tax Ratio	$0.28	$0.33	$0.13	$0.33
Income Tax Expense	$6.68M	$16.08M	$10.10M	$13.45M
Net Income	$49.48M	$46.09M	$11.59M	$38.33M
Net Income Ratio	$0.25	$0.25	$0.07	$0.25
EPS	$0.87	$0.81	$0.20	$0.68
Diluted EPS	$0.85	$0.79	$0.20	$0.67
Weighted Avg Shares Outstanding	$57.10M	$56.87M	$56.80M	$56.77M
Weighted Avg Shares Outstanding (Diluted)	$58.22M	$58.10M	$57.54M	$57.60M

Harmony Biosciences Holdings, Inc.